Studies show that the MHC class I-related chain (MIC) A and MICB ligands for the activating receptor NKG2D can be shed from tumor cells and their presence in patients’ plasma is closely associated with the compromised NK cell responses and disease progression [96, 97]. This evidence concerns the gene KLRK1 and neoplasm.